The Federal Trade Commission finalized changes to a rule that will require healthcare companies to provide more information to regulators ahead of merger and acquisition deals.
The agency said the changes that will improve the ability of the FTC and Antitrust Division of the U.S. Department of Justice (DOJ) to detect illegal mergers and acquisitions prior to consummation.
“The final rule requires additional information that is necessary to determine which deals require an in-depth antitrust investigation,” the FTC said in a press release.
Learn more about the premerger notification requirements here.